Key drivers of CVD in CKD include hyperphosphatemia and elevated levels of fibroblast growth factor-23 (FGF23), and recent studies have highlighted the role of the Klotho protein in mitigating these risks.2 The gene discussed is KL; the disease is hyperphosphatemia.